Brain White Matter Microstructural Alterations in Behcet’s Syndrome Correlate with Cognitive Impairment and Disease Severity: A Diffusion Tensor Imaging Study

Reducing Out-of-pocket Costs of Disease-modifying Therapies for Medicare Part D Beneficiaries with Multiple Sclerosis: A Call to Action for Neurologists

Whole Brain, Cortical Grey Matter, and Thalamic Volume Changes During 5–7 Years of Ozanimod in Relapsing MS: Final Results from the DAYBREAK Open-label Extension Study

Author:Cohen, Jeffrey A.   Arnold, Douglas L.   DeLuca, John   Hartung, Hans-Peter   Kappos, Ludwig   Comi, Giancarlo   Selmaj, Krzysztof W.   Steinman, Lawrence   Bar-Or, Amit   Montalban, Xavier   Havrdová, Eva K.   Sheffield, James K.   Pachai, Chahin   Cheng, Chun-Yen   Riolo, Jon V.   C,   

Session Name:P3: Multiple Sclerosis: Imaging of Demyelinating and Neuroinflammatory Diseases  

Topic:Multiple Sclerosis  

Program Number:P3.005  

Author Institution:Kessler Foundation, West Orange, New Jersey, and Department of Physical Medicine & Rehabilitation and Neurology & Neurosciences, Rutgers - New Jersey Medical School, Newark, New Jersey, USA, West Orange, NJ  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Sydney, Australia  Department of Neurology, Medical University of Vienna, Vienna, Austria  and Department of Neurology, Palacký University Olomouc, Olomouc, Czech Republic, Dusseldorf, Germany  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Headorgans, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  Vita-Salute San Raffaele University, and Casa di Cura Igea, Milan, Italy, Milan, Italy  Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, California, USA, Stanford, CA  Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA, Philadelphia, PA  Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain  Bristol Myers Squibb, Princeton, New Jersey, USA, Princeton, NJ  Bristol Myers Squibb, Princeton, New Jersey, USA, Bedminster, NJ  

Cross-sectional Comparison of Mean Upper Cervical Cord Area (MUCCA) in Demyelinating Diseases of the Central Nervous System